Atenolol vs Ipilimumab

## Atenolol vs Ipilimumab: Overview

This comparison examines the pharmacological differences between **Atenolol** and **Ipilimumab**.

## Mechanism of Action

**Atenolol**: Cardioselective beta-1 adrenergic receptor blocker without intrinsic sympathomimetic activity.

**Ipilimumab**: Fully human anti-CTLA-4 IgG1 monoclonal antibody that blocks CTLA-4 inhibitory signaling.

## Pharmacokinetics

**Half-life**: Atenolol — 6-7 hours; Ipilimumab — 14.7 days.

## Chemical Properties

**Molecular Formula**: Atenolol — C14H22N2O3; Ipilimumab — N/A.

**Molecular Weight**: Atenolol — 266.3360 g/mol; Ipilimumab — N/A.

**Type**: Atenolol — Small molecule; Ipilimumab — Antibody.